S5E04: Engineering Therapeutic Antibodies

Antibodies are proteins produced by our immune system that neutralize or help destroy abnormal cells and foreign agents, like bacteria and viruses. However, their utility extends beyond our bodies’ defense system. Antibodies can also be engineered in the lab to be used as therapies. Today, over 170 antibodies have been approved as medicines to treat a wide range of diseases including cancers, autoimmune diseases, infectious diseases and more. In this episode, co-host Maria Wilson chats with guests Yan Wu, VP and Senior Fellow, Antibody Engineering, and Paul Carter, Genentech Fellow, Antibody Engineering, to discuss all things antibodies! Learn about the history of therapeutic antibodies, how advances in antibody engineering are creating new classes of medicines, and the promising role of artificial intelligence in designing antibodies from scratch and optimizing their therapeutic activity. Read the full text transcript at

You can listen to S5E04: Engineering Therapeutic Antibodies online on Radio and Podcast. Open the player on this page to stream the available audio.

S5E04: Engineering Therapeutic Antibodies is an episode from Two Scientists Walk Into a Bar by Two Scientists Walk Into a Bar.

This episode is 00:29:27 long.

This episode was published on Jun 26, 2024.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Two Scientists Walk Into a Bar when more episodes are available from the podcast feed.